Dr. Michael Aragon, Chief Medical Officer of Outset Medical based in San Jose, California, discusses how the company is reducing the cost and complexity of dialysis with its first-of-its-kind technology, the Tablo Hemodialysis System. Tablo, which is FDA cleared for use from the hospital to home, combines consumer product simplicity and real-time water purification into a compact unit that delivers dialysis with sophisticated simplicity. He also discusses Outset’s continued momentum in the acute market, patient adoption, and early home success.
Michael Aragon joined Outset as Chief Medical Officer in September 2018, after 14 years of clinical practice as a founding partner and President of North Texas Kidney Consultants- DFW. He is board certified in Internal Medicine and Nephrology, receiving his training at the University of Texas Health Sciences Center in Houston. His clinical research focus has been on the expansion and improvement of home dialysis options for patients with renal disease.
Michael received his undergraduate degree from Texas A&M University, and his medical degree from The University of Texas Medical School.